Gastric acid, also known as stomach acid, is hydrochloric acid, the primary acidic constituent of gastric juice, synthesized by parietal cells within the gastric glands of the stomach lining. Human gastric pH typically ranges from one to three, a significantly lower value compared to most other animal species, yet comparable to that observed in carrion-eating carnivores, which necessitates robust defense against ingested pathogens.
This elevated acidity confers upon gastric acid a crucial protective function against pathogens. Furthermore, it is instrumental in protein digestion through the activation of digestive enzymes, which collectively hydrolyze lengthy amino acid chains. Gastric acid production is precisely regulated by feedback mechanisms, enhancing secretion as required, for instance, postprandially. Concurrently, other gastric cells generate bicarbonate, a base, to buffer the luminal fluid, thereby maintaining pH homeostasis. These cells also secrete mucus, forming a viscous protective barrier that safeguards the stomach from acid-induced damage. Additionally, the pancreas contributes substantial quantities of bicarbonate, secreting it via the pancreatic duct into the duodenum to neutralize gastric acid entering the digestive tract.
Gastric acid secretion represents a complex and metabolically demanding physiological process. Parietal cells possess an extensive secretory network, termed canaliculi, through which hydrochloric acid is discharged into the gastric lumen. The luminal pH is meticulously regulated by the H+/K+ ATPase proton pump. During this process, parietal cells release bicarbonate into the bloodstream, leading to a transient elevation in blood pH, a phenomenon referred to as an alkaline tide.
Gastric juice additionally comprises digestive enzymes synthesized by other cells within the gastric glands, specifically gastric chief cells. Gastric chief cells secrete pepsinogen in its inactive zymogen form. Upon entry into the stomach lumen, gastric acid catalyzes the activation of this proenzyme into pepsin.
Secretion
An adult human stomach typically secretes approximately 1.5 liters of gastric juice per day. Gastric juice constitutes a composite of gastric gland secretions, encompassing hydrochloric acid (gastric acid) as its principal component, along with gastric lipase and pepsinogen. Within the stomach, pepsinogen undergoes conversion by gastric acid into the active digestive enzyme pepsin, thereby augmenting the enzymatic content of the gastric juice. The pH of human gastric acid ranges from one to three, a considerably lower value than in most other animal species, yet closely resembling that of carrion-eating carnivores, which require enhanced protection against ingested pathogens.
The secretion of gastric acid proceeds through a multi-step process. Chloride and hydrogen ions are independently secreted from the parietal cell cytoplasm and subsequently combine within the canaliculi. This process establishes a transmembrane potential ranging from −40to−70mV across the parietal cell membrane, facilitating the diffusion of potassium ions and a minor quantity of sodium ions from the cytoplasm into the parietal cell canaliculi. Subsequently, gastric acid, alongside other glandular secretions, is discharged into the gastric pit for ultimate release into the stomach lumen.
The enzyme carbonic anhydrase catalyzes the reversible reaction between carbon dioxide and water, yielding carbonic acid. This carbonic acid promptly dissociates into hydrogen and bicarbonate ions. The hydrogen ions are then expelled from the cell via H+/K+ ATPase antiporter pumps.
Concurrently, sodium ions undergo active reabsorption. Consequently, the predominant portion of secreted K+ (potassium) and Na+ (sodium) ions is returned to the cytoplasm. Within the canaliculus, the secreted hydrogen and chloride ions combine and are subsequently discharged into the lumen of the oxyntic gland.
The maximal concentration of gastric acid attained within the stomach, specifically in the canaliculi, is 160mM. This concentration is approximately 3 million times greater than that of arterial blood, yet it remains nearly isotonic with other bodily fluids. While the lowest pH of the secreted acid is 0.8, it undergoes dilution within the stomach lumen, resulting in a pH range of one to three.
A modest, continuous basal secretion of gastric acid, typically less than 10mEq/hour, occurs inter-prandially.
Gastric acid secretion is characterized by three distinct phases, each contributing to an increased secretion rate for the digestion of a meal:
- The cephalic phase accounts for approximately thirty percent of total gastric acid secretion, stimulated by the anticipation of food consumption, as well as its smell or taste. This signaling originates from higher brain centers and is transmitted via the vagus nerve (Cranial Nerve X). The vagus nerve activates parietal cells to secrete acid and enterochromaffin-like (ECL) cells to release histamine. Furthermore, the vagus nerve (CN X) releases gastrin-releasing peptide onto G cells and inhibits somatostatin secretion from D cells.
- During the gastric phase, approximately sixty percent of the total acid required for a meal is secreted. Gastric acid secretion is stimulated by stomach distension and the presence of amino acids in ingested food.
- The intestinal phase contributes the remaining ten percent of acid secretion, occurring upon the entry of chyme into the small intestine. This secretion is stimulated by small intestinal distension and the presence of amino acids. Duodenal cells release entero-oxyntin, which directly influences parietal cells without impacting gastrin levels.
Regulation of Secretion
Gastric acid production is meticulously regulated by the autonomic nervous system and various hormones. The parasympathetic nervous system, primarily through the vagus nerve, and the hormone gastrin both stimulate parietal cells to produce gastric acid. This stimulation occurs directly on parietal cells and indirectly by promoting histamine secretion from enterochromaffin-like cells (ECLs). Conversely, vasoactive intestinal peptide, cholecystokinin, and secretin all exert inhibitory effects on gastric acid production.
Gastric acid production within the stomach is precisely controlled by both positive regulators and negative feedback mechanisms. This intricate process involves four primary cell types: parietal cells, G cells, D cells, and enterochromaffin-like cells. Additionally, the vagus nerve (CN X) endings and the intramural nervous plexus within the digestive tract significantly influence secretory activity.
Gastric nerve endings release two stimulatory neurotransmitters: acetylcholine and gastrin-releasing peptide. These substances act directly on parietal cells and indirectly by mediating the secretion of gastrin from G cells and histamine from enterochromaffin-like cells. Gastrin itself exerts both direct and indirect effects on parietal cells, partly by stimulating histamine release.
Histamine release represents the most crucial positive regulatory mechanism for gastric acid secretion in the stomach. Its secretion is stimulated by gastrin and acetylcholine, while somatostatin inhibits its release.
Neutralization
Within the duodenum, gastric acid undergoes neutralization by bicarbonate. This process concurrently inactivates gastric enzymes that operate optimally within an acidic pH range. Pancreatic bicarbonate secretion is stimulated by secretin, a polypeptide hormone activated and released from S cells in the duodenal and jejunal mucosa when the duodenal pH drops below 4.5 to 5.0. The neutralization reaction is represented by the following equation:
- HCl + NaHCO3 → NaCl + H2CO§45§
Carbonic acid rapidly equilibrates with carbon dioxide and water, a process catalyzed by carbonic anhydrase enzymes situated on the gut epithelial lining. This reaction results in a net release of carbon dioxide gas into the lumen during neutralization. In the absorptive regions of the upper intestine, such as the duodenum, both dissolved carbon dioxide and carbonic acid tend to equilibrate with the bloodstream, causing the majority of the gas generated during neutralization to be expelled via the lungs.
Clinical Significance
Gastroesophageal reflux disease (GERD) is a prevalent condition characterized by the recurrent backward flow of stomach acid into the esophagus. This acid reflux, commonly known as heartburn, can irritate the esophageal lining. The majority of individuals can manage GERD symptoms through lifestyle modifications and pharmacological interventions, particularly proton pump inhibitors and H2 blockers. Antacids can also be employed to neutralize gastric acid. In certain cases, surgical intervention may be necessary to alleviate symptoms.
Persistent inflammation of the gastric mucosa can progress to atrophic gastritis, which subsequently diminishes gastric acid secretion and leads to associated digestive complications.
Hypochlorhydria and achlorhydria refer to conditions where gastric acid levels are either low or entirely absent, respectively. These states can potentially compromise the body's defense against ingested pathogens, including Vibrio or Helicobacter bacteria.
Zollinger–Ellison syndrome is characterized by elevated gastrin levels, which consequently stimulate excessive gastric acid production, often resulting in the formation of gastric ulcers. Similarly, hypercalcemia can also lead to increased gastrin and gastric acid secretion, thereby contributing to ulcer development.
Conditions involving severe or prolonged vomiting can precipitate hypochloremic metabolic alkalosis, a state defined by reduced blood acidity due to the depletion of H+ ions and chloride.
History
The fundamental role of gastric acid in the digestive process was definitively established during the 1820s and 1830s through the pioneering work of William Beaumont. His observations were conducted on Alexis St. Martin, a patient who, following an accidental injury, developed a gastric fistula. This unique condition enabled Beaumont to directly observe digestion and extract gastric acid, thereby confirming its indispensable function in the digestive system.
Discovery and Development of Proton Pump Inhibitors
- Discovery and development of proton pump inhibitors
References
The Parietal Cell: Mechanism of Acid Secretion; Colorado State University. Archived on May 2, 2021, at the Wayback Machine.
- The Parietal Cell: Mechanism of Acid Secretion; Colorado State University Archived 2021-05-02 at the Wayback Machine